Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care
View More
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
Pinpointing Independent Prognostic Factors Related to Treatment Modality in Breast Cancer
August 22nd 2020Researchers indicated that these study findings could set a basis to pinpoint independent prognostic factors related to a treatment modality in patients with breast cancer and provide clarity for the assessment of surrogate markers for overall survival.
Overweight, Obese Patients with Breast Cancer May Benefit Less from Docetaxel Treatment
August 14th 2020Though the results still need to be confirmed, researchers suggested these findings indicate a need to better understand how BMI affects the biology, progression, and treatment efficacy of breast cancer.
Phase 3 IMpassion131 Study Fails to Meet Primary End Point of PFS in Metastatic TNBC
August 7th 2020The study evaluating atezolizumab in combination with paclitaxel compared to placebo plus paclitaxel did not meet its primary end point of progression-free survival in patients with metastatic triple-negative breast cancer.
Study Finds Medicaid Expanded States Diagnose Breast Cancer at Earlier Stage
July 24th 2020A Yale study found that states with expanded Medicaid diagnosed women with breast cancer at an earlier stage of disease and was associated with a reduced number of uninsured patients when compared to non-Medicaid expansion states.
Recognizing Factors Contributing to PTSD May Improve Clinical Care in Patients with Breast Cancer
July 8th 2020Researchers highlighted the importance of recognizing the environmental and biological factors that contribute to the development of PTSD, which can help inform clinical care and potentially reduce PTSD comorbidity.
Phase 3 IMpassion031 Study of Atezolizumab in Combination with Chemo Meets Primary Endpoint
June 18th 2020The combination demonstrated a statistically significant and clinically meaningful improvement in pathological complete response for the treatment of individuals with early triple-negative breast cancer, regardless of PD-L1 expression.
Study Supports Increased Referrals of Genetic Testing in African American Women
June 9th 2020A recent study demonstrated the validity of current breast cancer testing panels for use in African American women and provides a basis for increased referral of this patient population for cancer genetic testing.
Insulin Resistance May Contribute to Worse Prognosis in Black Women with Breast Cancer
May 16th 2020Insulin resistance was found to be 1 factor that contributes to the worse prognosis in breast cancer between black and white women, potentially through direct effects of insulin on the tumor insulin receptor.
PALB2 Germline Mutations Moderately Increased Risk of PALB2-Related Breast Cancer in China
May 9th 2020This study analyzed the full prevalence and spectrum of partner and localizer BRCA2 (PALB2) germline mutations in China, focusing on the associations between these PALB2 germline mutations and breast cancer risk.
Early GP Referrals Lead to Longer Survival, Earlier Diagnosis for Patients with Cancer
May 1st 2020A recent study led by led by King's College London and Public Health England examined 1.4 million patients of cancer via the National Cancer Registry and found that early GP referrals led to longer survival rates for patients.